Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saag
Steven G Deeks

Showing results (1-10 of 744) with videos related to

Pageof 75
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
How do HIV elite controllers do what they do?Michael Saag, Steven G Deeks
Lancet (London, England)|March 7, 2006
Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patientsSteven G Deeks
Nature|September 3, 2011
HIV: How to escape treatmentSteven G Deeks
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 6, 2009
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapySteven G Deeks
Annual Review of Medicine|November 25, 2010
HIV infection, inflammation, immunosenescence, and agingSteven G Deeks
Lancet (London, England)|June 20, 2006
The risk of treatment versus the risk of HIV replicationSteven G Deeks
Lancet (London, England)|December 20, 2003
Treatment of antiretroviral-drug-resistant HIV-1 infectionSteven G Deeks
Blood|September 1, 2012
HIV infection, lymphoid fibrosis, and diseaseSteven G Deeks
Nature|July 28, 2012
HIV: Shock and killSteven G Deeks
BMJ (Clinical Research Ed.)|June 24, 2006
Antiretroviral treatment of HIV infected adultsSteven G Deeks
Pageof 75

Showing results (1-10 of 744) with videos related to

Sort By:
Pageof 75
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
How do HIV elite controllers do what they do?Michael Saag, Steven G Deeks
Lancet (London, England)|March 7, 2006
Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patientsSteven G Deeks
Nature|September 3, 2011
HIV: How to escape treatmentSteven G Deeks
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 6, 2009
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapySteven G Deeks
Annual Review of Medicine|November 25, 2010
HIV infection, inflammation, immunosenescence, and agingSteven G Deeks
Lancet (London, England)|June 20, 2006
The risk of treatment versus the risk of HIV replicationSteven G Deeks
Lancet (London, England)|December 20, 2003
Treatment of antiretroviral-drug-resistant HIV-1 infectionSteven G Deeks
Blood|September 1, 2012
HIV infection, lymphoid fibrosis, and diseaseSteven G Deeks
Nature|July 28, 2012
HIV: Shock and killSteven G Deeks
BMJ (Clinical Research Ed.)|June 24, 2006
Antiretroviral treatment of HIV infected adultsSteven G Deeks
Pageof 75